New project will manufacture novel stem cell products for clinical trials in Type 1 Diabetes

The ISLET project is a multi-center collaboration of leading European researchers that has been awarded 8 million Euros in a 5-year period. The project will develop advanced stem cell products ready for use in clinical trials in Type 1 Diabetes. Professor Henrik Semb from DanStem is coordinating the project.